-
Comment Letter
CTLA-4 Blockade Resistance after Relatlimab and Nivolumab.
- Alexander M Menzies, Ines Pires da Silva, Claudia Trojaniello, Elisabeth Vieu, Rodabe N Amaria, Lisa Zimmer, Serigne N Lo, Elizabeth M Burton, Hussein A Tawbi, Dirk Schadendorf, Jean J Grob, Paolo A Ascierto, and Georgina V Long.
- Melanoma Institute Australia, Sydney, NSW, Australia.
- N. Engl. J. Med. 2022 Apr 28; 386 (17): 1668-1669.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..